A similar reduction of GZMB/CCL5-expressing CD4+ TILs was observed when a comparison was made between 1956 tumour-bearing WT mice and mice with a targeted disruption of the Lilrb4 gene (Extended Data Fig. 6f). This evidence concerns the gene LILRB4 and neoplasm.